CCM OPEN HF Registry for Heart Failure

This study, called the CCM OPEN HF Registry, is looking at how well Impulse Dynamics CCM technologies work for people with heart failure. These technologies are devices that help your heart pump better. Researchers want to see if using these devices can reduce how often and how long people with heart failure need to stay in the hospital. They also want to make sure the devices are safe over a long period. You might be able to join if you are 18 or older, have heart failure, and are getting or have already received an Impulse Dynamics CCM device. The study aims to enroll 5500 people and will follow them for up to 5 years.

Study design
This is an observational study, meaning researchers will watch and collect information from 5500 participants who are already using or will use CCM therapy. It is a single-arm study, so all participants will receive the CCM therapy.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for at least 5 years to assess the long-term safety and effectiveness of the CCM therapy.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07112924

CCM OPEN HF Registry

Recruiting
Not specifiedAges 18+Observational
Impulse Dynamics
~5,500 participants
Updated 2026-04-23 on ClinicalTrials.gov

At a glance

Recruiting sites
6 of 28 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Assess CCM's effect on the rate and length of stay of heart failure (HF) hospitalizations
Measured over 1 Year
+1 more outcome measured
Heart Failure

NCT07112924

Where you'd take part

This study runs at 28 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • AdventHealth Orlando

    Orlando, Floridastudy coordinator listed

    Not yet recruiting

  • AdventHealth Tampa

    Tampa, Floridastudy coordinator listed

    Not yet recruiting

  • Advocate Aurora Health-St. Lukes

    Milwaukee, Wisconsinstudy coordinator listed

    Not yet recruiting

  • Cardiovascular Associates of Mesa

    Mesa, Arizonastudy coordinator listed

    Recruiting

  • Cardiovascular Specialists of New England Research Foundation

    Londonderry, New Hampshirestudy coordinator listed

    Not yet recruiting

  • Centra Health, Inc. dba Stroobants Cardiovascular Center

    Lynchburg, Virginiastudy coordinator listed

    Recruiting

  • CHRISTUS Trinity Mother Frances Health System

    Tyler, Texasstudy coordinator listed

    Not yet recruiting

  • David Turbay, MD

    El Paso, Texasstudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • Anthony Hong · STUDY_DIRECTOR · Impulse Dynamics
  • Lee Ming Boo · STUDY_DIRECTOR · Impulse Dynamics

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patients who have /will be implanted with Impulse Dynamics CCM technologies (e.g. CCM or CCM-D when available) as determined by investigators
Willing and able to provide informed consent, including for use of data for research purposes (e.g. publication, sub-studies/sub-analyses)

Exclusion

Noncompliant patients (e.g. for follow-up visits, medication, etc.) as determined by investigators.
Subjects with a mechanical tricuspid valve
  • Assess CCM's effect on the rate and length of stay of heart failure (HF) hospitalizations1 Year

    Change in the HF hospitalization / urgent HF visit rate and hospital length of stay from 1 year prior to 1 year following index implantation.

  • Demonstrate the long-term safety of CCM therapy in a real-world setting, by assessing the rate of device- or procedure-related complications.5 Years

    Rate of freedom from a composite of device- or procedure-related complication post-index implantation procedure. Serious procedure related complications occurring through the end of 30 days following the index procedure. Serious CCM device-related complications\* occurring through the end of 1-year following the index procedure. \* excluding lead-related complications